Patent · US Active

Modified release tablet of bupropion hydrochloride

US7537784B2 · kind B2 · utility

2Cited by

112References

16Claims

0Family size

Assignee

Biovail Laboratories International S.R.L. · BB

Inventors

Werner Oberegger · Mississauga, CA
Okponanabofa Eradiri · Ashburn, US
Fang Zhou · Pembroke Pines, US
Paul Maes · Toronto, CA

Key dates

Filing date	Jun 13, 2006
Grant date	May 26, 2009
Priority date	—
Expiry date	Apr 11, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2866
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A modified-release tablet of bupropion hydrochloride comprising (i) a core comprising an effective amount of bupropion hydrochloride, a binder, a lubricant; and (ii) a control releasing coat surrounding said core; and (iii) a moisture barrier surrounding said control releasing coat, wherein the modified-release tablet is bioequivalent to Wellbutrin® or Zyban®/Wellbutrin®SR tablets.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.